Author: BusinessWire

Experian Accelerates Identity and Activation Capabilities With Acquisition of Audigent

December 4, 2024

December 04 – COSTA MESA, Calif.–(BUSINESS WIRE)–Experian® — the global data and technology company — announced today it has acquired Audigent, a leading data activation and identity platform in the advertising industry. The acquisition further expands Experian’s deeply integrated marketing data and identity capabilities in the advertising ecosystem. With the addition of Audigent’s combined first-party publisher […]

AmorSui Announces $3.5M Seed Funding to Revolutionize Sustainable Medical Supplies

September 17, 2024

NEW YORK–(BUSINESS WIRE)–AmorSui, a modern personal protective equipment (PPE) brand dedicated to protecting people and the planet, announced today that it has raised $3.5 million in seed funding. AmorSui’s mission is to make PPE more sustainable, inclusive, and affordable over time, setting a new benchmark of quality in the medical supply sector. Investors include Gold […]

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation For NTX-001 And Provides Update On The Advancements Of NTX-001 For The Treatment Of Peripheral Nerve Injury Requiring Repair

September 11, 2024

CHESTERBROOK, Pa.–(BUSINESS WIRE)–Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for accelerated development for patients with peripheral nerve injury requiring repair. This designation follows the results from the Phase 2 NEUROFUSE study and several interactions with the FDA. NTX-001 has the potential to be a groundbreaking […]

Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing

May 6, 2024

Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing. The funding round is being led by 8VC and DCVC Bio. To date, Samsung Life Science Fund (created by Samsung […]

Cagent Vascular Raises $30 Million Series C Financing

February 22, 2024

Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only Serration Angioplasty Technology Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M. U.S. Venture Partners (USVP), led the round. Participation included new […]

SAIL Fusion Announces First Implantations Of Its BowTie™ Sacroiliac Fusion System

October 18, 2023

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon AO principles, today announced that it has conducted the first implantations of its novel BowTie SI Fusion System. The surgeries began on October 14th and were conducted by Dr. Peter Whang, Associate Professor of Orthopaedics […]

Cagent Vascular Announces Initial RECOIL Study Results: Serranator Demonstrates 49% Less Recoil Than POBA In BTK Arteries

July 19, 2023

Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee (BTK) RECOIL study. This Core Lab-Adjudicated Recoil analysis, the first of its kind, evaluated vessel recoil in lesions treated with Serranator® verses Plain Old Balloon Angioplasty (POBA). The study results demonstrated that lesions treated using […]

CampusESP Welcomes Customer 300: University Of Kentucky

April 19, 2023

CampusESP, the leading provider of technology solutions that help colleges and universities engage parents and families, announced today that it signed its 300th customer, the University of Kentucky. Founded in 2016, CampusESP has built a reputation as the go-to leader in parent and family engagement solutions, leading with the message that a strong family […]

WizeHive Combines Forces with Bright Funds to Create Comprehensive Corporate Giving Solution

November 18, 2021

WizeHive, a leading provider of Grants Management software, today announced a merger with Bright Funds, a leading provider of workplace giving and volunteerism solutions. By bringing together two best-of-breed software providers that power corporate philanthropic missions, WizeHive and Bright Funds will deliver a single SaaS solution that meets the full range of corporate giving needs […]

University of Kentucky, Children’s Hospital of Philadelphia and Mitochon Pharmaceuticals Awarded NIH Grant for Traumatic Brain Injury Studies

June 23, 2020

Mitochon Pharmaceuticals today announced that they, in partnership with the University of Kentucky (UK) and Children’s Hospital of Philadelphia (CHOP), were awarded a $3.2M National Institutes of Health grant to study Mitochon’s mitochondrial targeted drug therapies for treating Traumatic Brain Injury (TBI). This important award, along with the Company’s open IND, will help pave the […]